FDA approves Johnson & Johnson's nasal spray for depression

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Johnson & Johnson is set to report earnings before the bell Wednesday, with analysts expecting revenue and profit growth from ...
Johnson & Johnson has underperformed its large-cap healthcare peers and the S&P 500, with an -8% decline over the past year.
In a report released today, Tim Anderson from Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research ...
Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...
Johnson sent shockwaves around Capitol Hill when he decided to oust Rep. Mike Turner, R-Ohio — a staunch NATO supporter who ...
The speaker replaced a Republican who had criticized the president-elect and broken with him on key issues, and who had drawn ...